|
Tasigna® receives US approval providing new hope to chronic myeloid leukemia patients
|
02 November 2007 |
|
Novartis delivers record earnings in first nine months of 2007
|
20 October 2007 |
|
Aclasta® receives European approval as first once-yearly treatment for postmenopausal osteoporosis
|
08 October 2007 |
|
Novartis and Massachusetts Institute of Technology (MIT) in new partnership
|
01 October 2007 |
|
Tasigna® recommended for European approval to treat rare form of leukemia
|
24 September 2007 |
|
Novartis completes agreement with Bayer Schering related to Betaseron®
|
15 September 2007 |
|
Novartis to defend its intellectual property rights for Famvir®
|
08 September 2007 |
|
Novartis completes divestment program with transfer of Gerber baby foods business
|
07 September 2007 |
|
Novartis Completes Divestment of Medical Nutrition Business
|
02 July 2007 |
|
Sandoz Receives Positive EU Opinion for Approval of epoetin alfa biosimilar
|
22 June 2007 |